Ceftolozane/Tazobactam for Resistant Drugs Pseudomonas aeruginosa Respiratory Infections: A Systematic Literature Review of the Real-World Evidence

Background: Ceftolozane/tazobactam (C/T) is a β-lactam/β-lactamase inhibitor combination that mainly targets Gram-negative bacteria. The current international guidelines recommend including C/T treatment in the empirical therapy for hospital-acquired pneumonia (HAP) and ventilator-associated pneumon...

Descripción completa

Detalles Bibliográficos
Autores principales: Giaccari, Luca Gregorio, Pace, Maria Caterina, Passavanti, Maria Beatrice, Gargano, Francesca, Aurilio, Caterina, Sansone, Pasquale
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8225018/
https://www.ncbi.nlm.nih.gov/pubmed/34073847
http://dx.doi.org/10.3390/life11060474

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8225018/
https://www.ncbi.nlm.nih.gov/pubmed/34073847
http://dx.doi.org/10.3390/life11060474

Ejemplares similares